722 related articles for article (PubMed ID: 37060495)
1. Pathological angiogenesis: mechanisms and therapeutic strategies.
Dudley AC; Griffioen AW
Angiogenesis; 2023 Aug; 26(3):313-347. PubMed ID: 37060495
[TBL] [Abstract][Full Text] [Related]
2. Tumour vascularization: sprouting angiogenesis and beyond.
Hillen F; Griffioen AW
Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.
Bousseau S; Vergori L; Soleti R; Lenaers G; Martinez MC; Andriantsitohaina R
Pharmacol Ther; 2018 Nov; 191():92-122. PubMed ID: 29909237
[TBL] [Abstract][Full Text] [Related]
4. [Rationale of antiangiogenic therapy].
Tímár J; Paku S; Tóvári J; Döme B
Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
[TBL] [Abstract][Full Text] [Related]
5. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
Tammela T; Zarkada G; Wallgard E; Murtomäki A; Suchting S; Wirzenius M; Waltari M; Hellström M; Schomber T; Peltonen R; Freitas C; Duarte A; Isoniemi H; Laakkonen P; Christofori G; Ylä-Herttuala S; Shibuya M; Pytowski B; Eichmann A; Betsholtz C; Alitalo K
Nature; 2008 Jul; 454(7204):656-60. PubMed ID: 18594512
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
[TBL] [Abstract][Full Text] [Related]
7. Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy.
Mohammadi P; Yarani R; Rahimpour A; Ranjbarnejad F; Mendes Lopes de Melo J; Mansouri K
Drug Metab Rev; 2022 Nov; 54(4):386-400. PubMed ID: 36031813
[TBL] [Abstract][Full Text] [Related]
8. Intussusceptive angiogenesis as a key therapeutic target for cancer therapy.
Saravanan S; Vimalraj S; Pavani K; Nikarika R; Sumantran VN
Life Sci; 2020 Jul; 252():117670. PubMed ID: 32298741
[TBL] [Abstract][Full Text] [Related]
9. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.
Shao Y; Lu B
Cancer Metastasis Rev; 2022 Mar; 41(1):173-191. PubMed ID: 34664157
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
12. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
Maes H; Olmeda D; Soengas MS; Agostinis P
FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
15. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
16. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.
Döme B; Hendrix MJ; Paku S; Tóvári J; Tímár J
Am J Pathol; 2007 Jan; 170(1):1-15. PubMed ID: 17200177
[TBL] [Abstract][Full Text] [Related]
17. Overview on the Different Patterns of Tumor Vascularization.
Ribatti D; Pezzella F
Cells; 2021 Mar; 10(3):. PubMed ID: 33805699
[TBL] [Abstract][Full Text] [Related]
18. Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy.
Jones D
Cells; 2020 Mar; 9(3):. PubMed ID: 32244922
[TBL] [Abstract][Full Text] [Related]
19. Inducing vascular normalization: A promising strategy for immunotherapy.
Luo X; Zou W; Wei Z; Yu S; Zhao Y; Wu Y; Wang A; Lu Y
Int Immunopharmacol; 2022 Nov; 112():109167. PubMed ID: 36037653
[TBL] [Abstract][Full Text] [Related]
20. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
Takakura N
Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
